Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 5' Nor Anhydrovinblastine
2. 5'-nor-anhydrovinblastine
3. Kw 2307
4. Kw-2307
5. Kw2307
6. Navelbine
7. Vinorelbine
8. Vinorelbine Tartrate
1. Vinorelbine Tartrate
2. 125317-39-7
3. Vinorelbine Ditartrate
4. 5'-noranhydrovinoblastine Tartrate
5. Vinorelbine Ditartrate Salt Hydrate
6. Vinorelbinetartrate
7. 1217449-57-4
8. Vinorelbine, Ditartrate
9. Vinorelbine Ditartaric Acid
10. 317v397
11. Q-100110
12. (2r,3r)-2,3-dihydroxybutanedioic Acid;methyl (1r,9r,10s,11r,12r,19r)-11-acetyloxy-12-ethyl-4-[(12s,14s)-16-ethyl-12-methoxycarbonyl-1,10-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8,15-pentaen-12-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate
13. Methyl (3ar,3a1r,4r,5s,5ar,10br)-4-acetoxy-3a-ethyl-9-((6s,8s)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methanoazecino[4,3-b]indol-8-yl)-5-hydroxy-8-methoxy-6-methyl-3a,3a1,4,5,5a,6,11,12-octahydro-1h-indolizino[8,1-cd]carbazole-5-carboxylate Bis((2r,3r)-2,3-dihydroxysuccinate)
| Molecular Weight | 1079.1 g/mol |
|---|---|
| Molecular Formula | C53H66N4O20 |
| Hydrogen Bond Donor Count | 10 |
| Hydrogen Bond Acceptor Count | 23 |
| Rotatable Bond Count | 16 |
| Exact Mass | 1078.42704051 g/mol |
| Monoisotopic Mass | 1078.42704051 g/mol |
| Topological Polar Surface Area | 364 Ų |
| Heavy Atom Count | 77 |
| Formal Charge | 0 |
| Complexity | 1820 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 12 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
| 1 of 2 | |
|---|---|
| Drug Name | VINORELBINE TARTRATE |
| Active Ingredient | VINORELBINE TARTRATE |
| Company | ACTAVIS TOTOWA (Application Number: A078011); DR REDDYS LABS LTD (Application Number: A202017); FRESENIUS KABI USA (Application Number: A076849); HOSPIRA (Application Number: A076827); JIANGSU HANSOH PHARM (Application Number: A091106); TEVA PHARMS USA (Application Number: A076028); WEST-WARD PHARMS INT (Application Number: A075992); WEST-WARD PHARMS INT (Application Number: A076461) |
| 2 of 2 | |
|---|---|
| Drug Name | NAVELBINE |
| Active Ingredient | VINORELBINE TARTRATE |
| Company | PIERRE FABRE (Application Number: N020388) |
Antineoplastic Agents, Phytogenic
Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)
Tubulin Modulators
Agents that interact with TUBULIN to inhibit or promote polymerization of MICROTUBULES. (See all compounds classified as Tubulin Modulators.)
Market Place
ABOUT THIS PAGE
A Navelbine Tartrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Navelbine Tartrate, including repackagers and relabelers. The FDA regulates Navelbine Tartrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Navelbine Tartrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Navelbine Tartrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Navelbine Tartrate supplier is an individual or a company that provides Navelbine Tartrate active pharmaceutical ingredient (API) or Navelbine Tartrate finished formulations upon request. The Navelbine Tartrate suppliers may include Navelbine Tartrate API manufacturers, exporters, distributors and traders.
click here to find a list of Navelbine Tartrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Navelbine Tartrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Navelbine Tartrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Navelbine Tartrate GMP manufacturer or Navelbine Tartrate GMP API supplier for your needs.
A Navelbine Tartrate CoA (Certificate of Analysis) is a formal document that attests to Navelbine Tartrate's compliance with Navelbine Tartrate specifications and serves as a tool for batch-level quality control.
Navelbine Tartrate CoA mostly includes findings from lab analyses of a specific batch. For each Navelbine Tartrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Navelbine Tartrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Navelbine Tartrate EP), Navelbine Tartrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Navelbine Tartrate USP).
LOOKING FOR A SUPPLIER?
